Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
- PMID: 33852795
- PMCID: PMC8063883
- DOI: 10.1056/NEJMc2105869
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
Comment in
-
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Response from the Manufacturer.N Engl J Med. 2021 May 20;384(20):1965-1966. doi: 10.1056/NEJMc2106075. Epub 2021 Apr 16. N Engl J Med. 2021. PMID: 33861522 Free PMC article. No abstract available.
References
-
- Greinacher A, Selleng K, Warkentin TE. Autoimmune heparin-induced thrombocytopenia. J Thromb Haemost 2017;15:2099-2114. - PubMed
-
- Warkentin TE. High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review. Expert Rev Hematol 2019;12:685-698. - PubMed
-
- Zhang R, Hefter Y. FDA review of efficacy and safety of the Janssen COVID-19 vaccine emergency use authorization request, February 26, 2021. (https://www.fda.gov/media/146267/download).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical